Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) sightings, coupled with the globally prevailing coronavirus disease 2019 (COVID‐19) pandemic, are triggering public health emergencies worldwide. In order to assess any role and / or effectiveness of convalescent plasma (CP) therapy among patients presenting with COVID‐19, the current descriptive study was conducted. One hundred patients, who were presenting COVID‐19, were enrolled. These patients were then made to receive ABO‐compatible CP transfusion. Effectiveness of this intrusion was then ascertained by recoveries in symptoms, changes in radiologic deformations, as well as through laboratory tests. This study did not observe any palpable adverse effect during the course of this mode of treatment. The elected course of CP led transfusion presented a lead to settlement of ground‐glass opacities, along with strengthening among the enrolled COVID-19 patients, and removal of virus were relatively quicker. This study supported the effectiveness of CP therapy for patients with COVID‐19. The selected mode of intervention, which also presented to carry a significant role to oust SARS‐CoV‐2, is also found to be a promising therapy mode for COVID‐19. Key words: Convalescent plasma, Lungs infiltrates, COVID 19.